Last reviewed · How we verify
NCT03494140
Viscontour® Serum Med in Hydration of Facial Skin
trial testing Viscontour® Serum Med in Sodium Hyaluronate in 40 participants. Completed in 18 August 2018.
18 August 2018
Quick facts
| Lead sponsor | TRB Chemedica AG |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 18 April 2018 |
| Primary completion | 18 August 2018 |
| Estimated completion | 18 August 2018 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Viscontour® Serum Med
Conditions studied
- Sodium Hyaluronate — all drugs for Sodium Hyaluronate →
Sponsor
TRB Chemedica AG
Who can join
18 and older, female only, with Sodium Hyaluronate. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to confirm the clinical safety and efficacy of Viscontour® Serum Med in the hydration of facial tissue.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03494140
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other TRB Chemedica AG trials
Trials by the same sponsor.
- NCT04757051 — Real-life Use of BENART TM in Patients With Symptomatic Knee Osteoarthritis · completed
- NCT03879434 — Routine Application of Ostenil® Mini in Patients with Rhizarthrosis · completed
- NCT03809962 — Efficacy and Safety of Ostenil® Plus in the Treatment of Coxarthrosis · completed
- NCT03734315 — Routine Application of Ostenil® in Patients with Gonarthrosis · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03494140 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by TRB Chemedica AG
- Last refreshed: 18 September 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03494140.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing